Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Peter_Fromen
|
| gptkbp:country |
gptkb:United_Kingdom
|
| gptkbp:focusesOn |
genomics
biomarker discovery epigenetics DNA methylation analysis |
| gptkbp:foundedBy |
gptkb:Sir_Shankar_Balasubramanian
gptkb:Sir_David_Klenerman |
| gptkbp:foundedYear |
2012
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:investor |
gptkb:Ahren_Innovation_Capital
gptkb:New_Science_Ventures gptkb:GV gptkb:Sequoia_Capital |
| gptkbp:location |
gptkb:Cambridge,_United_Kingdom
|
| gptkbp:technology |
epigenetic sequencing
|
| gptkbp:website |
https://www.cambridge-epigenetix.com/
|
| gptkbp:bfsParent |
gptkb:Wellcome_Trust_Sanger_Institute
|
| gptkbp:bfsLayer |
5
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cambridge Epigenetix
|